| Name | Title | Contact Details |
|---|
Advantage Vending is a Boonton, NJ-based company in the Business Services sector.
Langham Hospitality Group is a global hotel company headquartered in Hong Kong, operating under Great Eagle Holdings. The group has a rich history dating back to 1865 with the opening of The Langham in London, recognized as Europes first Grand Hotel. This landmark set a standard for luxury hospitality and has welcomed many notable guests over the years. The group offers luxury hospitality services through its brands, including The Langham Hotels and Resorts and Cordis Hotels, with a presence in major cities across Asia Pacific, North America, the UK, and Europe. Langham Hospitality Group is dedicated to providing elegant design and innovative services, ensuring a captivating experience for its guests. With over 30 properties managed worldwide, the company is a significant player in the luxury hospitality sector, committed to sustainable development through its CONNECT programme.
Ashworth Awards is a North Attleboro, MA-based company in the Business Services sector.
Blue Endeavors is a nonprofit that creates advocates for the ocean. We educate people — through scuba diving training and citizen science curriculum — on how to minimize our impact on the oceans and take action to create positive change.
Ultima Genomics is unleashing the power of genomics at scale. Our mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. With humanity on the cusp of a biological revolution, there is a virtually endless need for more genomic information to address biologys complexity and dynamic change—and a further need to challenge conventional next-generation sequencing technologies. Ultimas revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth, and frequency with which they use genomic information. The new sequencing architecture was designed to scale far beyond conventional sequencing technologies, lower the cost of genomic information and catalyze the next phase of genomics in the 21st century.